This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In the QUESTIONS AND ANSWERS section of the Feb 7 issue of The Journal (237:579, 1977), an incorrect drug was mentioned in the answer to a question concerning recurrent herpes simplex and concomitant headaches for 12 years. On page 579, column 2, lines 5 and 6, the drug used for intralesional injections should be triamcinolone acetonide (Kenalog) enanthate or triamcinolone hexacetonide (Aristospan) instead of the topical cream triamcinolone acetonide (Aristocort A).
Herpes Simplex Treatment. JAMA. 1977;237(18):1930. doi:10.1001/jama.1977.03270450020011
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: